CXCR4 signalling, metastasis and immunotherapy: zebrafish xenograft model as translational tool for anti-cancer discovery

Claudia Tulotta , B. Ewa Snaar-Jagalska

Journal of Cancer Metastasis and Treatment ›› 2019, Vol. 5 : 74

PDF
Journal of Cancer Metastasis and Treatment ›› 2019, Vol. 5:74 DOI: 10.20517/2394-4722.2019.022
Review
review-article

CXCR4 signalling, metastasis and immunotherapy: zebrafish xenograft model as translational tool for anti-cancer discovery

Author information +
History +
PDF

Abstract

Cell-to-cell communication guarantees homeostasis in a multi-cellular organism. Cancer-to-microenvironment communication sustains malignant growth and dissemination. Whereas the accumulation of mutations is at the origin of malignant cell transformation and neoplasia onset, the interaction between cancer and the surrounding stroma, specifically immune cells, influences the balance between tumour regression and tumour progression. To study how the interaction between cancer and stromal cells is disadvantageous or beneficial for tumour progression, the use of a transparent in vivo model bears important research potentials. Zebrafish has been increasingly used as animal model to study tumour biology. The use of transparent zebrafish embryos, with fluorescent endothelial and immune cells, allows the visualization of cell-to-cell interaction, among host cells themselves and between zebrafish stroma and implanted human cancer cells. Here, we summarise our findings on the role of CXCR4 signalling in tumour progression, considering its signature both on cell autonomous and host dependent mechanisms. Finally, we address the translational impact of targeting CXCR4 signalling in cancer and the tumour microenvironment for the treatment of metastatic cancer.

Keywords

CXCR4 / cancer / metastasis / neutrophils / zebrafish / immunotherapy

Cite this article

Download citation ▾
Claudia Tulotta, B. Ewa Snaar-Jagalska. CXCR4 signalling, metastasis and immunotherapy: zebrafish xenograft model as translational tool for anti-cancer discovery. Journal of Cancer Metastasis and Treatment, 2019, 5: 74 DOI:10.20517/2394-4722.2019.022

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Hanahan D.Hallmarks of cancer: the next generation..Cell2011;144:646-74

[2]

Klemm F.Microenvironmental regulation of therapeutic response in cancer..Trends Cell Biol2015;25:198-213

[3]

Granot Z.Plasticity beyond cancer cells and the “Immunosuppressive Switch”..Cancer Res2015;75:4441-5

[4]

Coffelt SB,Doornebal CW,Vrijland K.IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis..Nature2015;522:345-8 PMCID:PMC4475637

[5]

Wang J.Chemokine signaling in development and disease..Development2014;141:4199-205 PMCID:PMC4302920

[6]

Zlotnik A.The chemokine superfamily revisited..Immunity2012;36:705-16 PMCID:PMC3396424

[7]

Karnoub AE.Chemokine networks and breast cancer metastasis..Breast Dis2006;26:75-85

[8]

Kiefer F.The role of chemokines and their receptors in angiogenesis..Cell Mol Life Sci2011;68:2811-30

[9]

Boldajipour B,Kardash E,Blaser H.Control of chemokine-guided cell migration by ligand sequestration..Cell2008;132:463-73

[10]

Dona E,Valentin G,Khmelinskii A.Directional tissue migration through a self-generated chemokine gradient..Nature2013;503:285-9

[11]

Venkiteswaran G,Wang J,Nicholson C.Generation and dynamics of an endogenous, self-generated signaling gradient across a migrating tissue..Cell2013;155:674-87 PMCID:PMC3842034

[12]

Pawig L,Weber C,Noels H.Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives..Front Immunol2015;6:429 PMCID:PMC4543903

[13]

Scala S.Molecular pathways: targeting the CXCR4-CXCL12 axis-untapped potential in the tumor microenvironment..Clin Cancer Res2015;21:4278-85

[14]

Nguyen DX,Massague J.Metastasis: from dissemination to organ-specific colonization..Nat Rev Cancer2009;9:274-84

[15]

Xue LJ,Ren LL.Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma..Cancer Med2017;6:1424-36 PMCID:PMC5463074

[16]

Mitchell B.The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma..Histol Histopathol2014;29:1539-46

[17]

Xu CZ,Yan XJ,Chen D.Expression of CXCR4 is associated with progression and invasion in patients with nasal-surface basal cell carcinoma..ORL J Otorhinolaryngol Relat Spec2013;75:332-41

[18]

Knopf A,Fritsche K,Becker CC.Primary tumor-associated expression of CXCR4 predicts formation of local and systemic recurrency in head and neck squamous cell carcinoma..Oncotarget2017;8:112739-47 PMCID:PMC5762546

[19]

Wald O.CXCR4 based therapeutics for non-small cell lung cancer (NSCLC)..J Clin Med2018;7:E303 PMCID:PMC6210654

[20]

Xu C,Chen H.CXCR4 in breast cancer: oncogenic role and therapeutic targeting..Drug Des Devel Ther2015;9:4953-64 PMCID:PMC4560524

[21]

Figueras A,Lahiguera A,Muinelo-Romay L.A role for CXCR4 in peritoneal and hematogenous ovarian cancer dissemination..Mol Cancer Ther2018;17:532-43

[22]

Bao Y,Liu B,Xiong Y.A feed-forward loop between nuclear translocation of CXCR4 and HIF-1alpha promotes renal cell carcinoma metastasis..Oncogene2019;38:881-95 PMCID:PMC6367212

[23]

Zhu WB,Zhou X.AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1alpha/CXCR4 signaling pathway in prostate cancer..J Cell Physiol2019;234:11746-59

[24]

Richardson PJ.CXCR4 and glioblastoma..Anticancer Agents Med Chem2016;16:59-74

[25]

Sand LG,Berghuis D,Picci P.CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients..Eur J Cancer2015;51:2624-33

[26]

Du W,Zhu X,Chen X.Prognostic significance of CXCR4 expression in acute myeloid leukemia..Cancer Med2019;

[27]

Choi WT,Xu Y.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis..Curr Top Med Chem2014;14:1574-89 PMCID:PMC4372248

[28]

Guo F,Liu J,Xue F.CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks..Oncogene2016;35:816-26

[29]

Sugihara H,Yasuda T,Eto K.Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction..Med Oncol2015;32:618

[30]

Fearon DT.The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance..Cancer Immunol Res2014;2:187-93

[31]

Feig C,Kraman M,Deonarine A.Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer..Proc Natl Acad Sci U S A2013;110:20212-7 PMCID:PMC3864274

[32]

Brandau S,Bruderek K,Steller G.Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties..J Leukoc Biol2011;89:311-7

[33]

Contento RL,Boularan C,Manes S.CXCR4-CCR5: a couple modulating T cell functions..Proc Natl Acad Sci U S A2008;105:10101-6 PMCID:PMC2481367

[34]

Strydom N.Regulation of circulating neutrophil numbers under homeostasis and in disease..J Innate Immun2013;5:304-14

[35]

Zou L,Safah H,Evdemon-Hogan M.Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals..Cancer Res2004;64:8451-5

[36]

Jablonska J,Westphal K,Weiss S.Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model..J Clin Invest2010;120:1151-64 PMCID:PMC2846036

[37]

Hughes R,Rowan C,Keklikoglou I.Perivascular M2 macrophages stimulate tumor relapse after chemotherapy..Cancer Res2015;75:3479-91 PMCID:PMC5024531

[38]

Ping YF,Jiang JY,Yu SC.The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling..J Pathol2011;224:344-54

[39]

Beider K,Leiba M,Koren-Michowitz M.Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype..Oncotarget2014;5:11283-96 PMCID:PMC4294328

[40]

Gil M,Seshadri M,McGray AJ.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells..J Immunol2014;193:5327-37 PMCID:PMC4225176

[41]

Guo ZS.The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer)..BMC Cancer2018;18:1086 PMCID:PMC6231274

[42]

Chen IX,Posada J,Wu MW.Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer..Proc Natl Acad Sci U S A2019;116:4558-66 PMCID:PMC6410779

[43]

Patton EE,Amatruda JF.Spotlight on zebrafish: translational impact..Dis Model Mech2014;7:731-3 PMCID:PMC4073261

[44]

Antonio N,Ward LC,Christensen IJ.The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer..EMBO J2015;34:2219-36 PMCID:PMC4585460

[45]

Feng Y,Martin P.Live imaging of tumor initiation in zebrafish larvae reveals a trophic role for leukocyte-derived PGE(2)..Curr Biol2012;22:1253-9 PMCID:PMC3398414

[46]

Feng Y,Mione M,Martin P.Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation..PLoS Biol2010;8:e1000562 PMCID:PMC3001901

[47]

Kimmel CB,Kimmel SR,Schilling TF.Stages of embryonic development of the zebrafish..Dev Dyn1995;203:253-310

[48]

Ellett F,Hayman JW,Lieschke GJ.mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish..Blood2011;117:e49-56 PMCID:PMC3056479

[49]

Lawson ND.In vivo imaging of embryonic vascular development using transgenic zebrafish..Dev Biol2002;248:307-18

[50]

Renshaw SA,Trushell DM,Ingham PW.A transgenic zebrafish model of neutrophilic inflammation..Blood2006;108:3976-8

[51]

Gonzales AP.Cas9-based genome editing in zebrafish..Methods Enzymol2014;546:377-413

[52]

Lawson ND.Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish..Dev Cell2011;21:48-64

[53]

Robertson AL,Bojarczuk AN,Loynes CA.A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism..Sci Transl Med2014;6:225ra29 PMCID:PMC4247228

[54]

Goessling W,Zon LI.New waves of discovery: modeling cancer in zebrafish..J Clin Oncol2007;25:2473-9

[55]

Ung CY,Gong Z.Comparative transcriptome analyses revealed conserved biological and transcription factor target modules between the zebrafish and human tumors..Zebrafish2009;6:425-31

[56]

Amatruda JF,Stern HM.Zebrafish as a cancer model system..Cancer Cell2002;1:229-31

[57]

Letrado P,Lamberto I,Oyarzabal J.Zebrafish: speeding up the cancer drug discovery process..Cancer Res2018;78:6048-58

[58]

van der Ent W,Groenewoud A,Tulotta C.Automation of technology for cancer research..Adv Exp Med Biol2016;916:315-32

[59]

Zon LI.In vivo drug discovery in the zebrafish..Nat Rev Drug Discov2005;4:35-44

[60]

He SN,Beenakker JWM,Ghotra VPS.Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model..J Pathol2012;227:431-45 PMCID:PMC3504093

[61]

Tulotta C,Chen L,van der Ent W.Imaging of human cancer cell proliferation, invasion, and micrometastasis in a Zebrafish xenogeneic engraftment model..Methods Mol Biol2016;1451:155-69

[62]

Tulotta C,van der Ent W,Groenewoud A.Imaging cancer angiogenesis and metastasis in a Zebrafish embryo model..Adv Exp Med Biol2016;916:239-63

[63]

Astone M,Alam SK.Fishing for cures: the alLURE of using zebrafish to develop precision oncology therapies..NPJ Precis Oncol2017;1:39 PMCID:PMC5784449

[64]

Gaudenzi G,Dicitore A,Gatto F.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors..Endocrine2017;57:214-9

[65]

Mercatali L,Groenewoud A,Recine F.Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a Zebrafish model..Int J Mol Sci2016;17:E1375 PMCID:PMC5000770

[66]

Wu JQ,Li CY,Wei P.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer..J Exp Clin Cancer Res2017;36:160 PMCID:PMC5688753

[67]

Tulotta C,Snaar-Jagalska BE.Animal models of breast cancer bone metastasis..Methods Mol Biol2019;1914:309-30

[68]

Vazquez Rodriguez G,Jensen LD.Estradiol promotes breast cancer cell migration via recruitment and activation of neutrophils..Cancer Immunol Res2017;5:234-47

[69]

Kiener M,Krebs M,Klima I.miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo..BMC Cancer2019;19:627 PMCID:PMC6593572

[70]

Ghotra VP,van der Horst G,de Bont H.SYK is a candidate kinase target for the treatment of advanced prostate cancer..Cancer Res2015;75:230-40

[71]

Canella A,Yoo JY,Abas FS.Efficacy of Onalespib, a long-acting second-generation HSP90 inhibitor, as a single agent and in combination with temozolomide against malignant gliomas..Clin Cancer Res2017;23:6215-26 PMCID:PMC5986078

[72]

Vandercappellen J,Struyf S.The role of CXC chemokines and their receptors in cancer..Cancer Lett2008;267:226-44

[73]

Nagasawa T,Tachibana K,Nishikawa S.Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1..Nature1996;382:635-8

[74]

Rosu-Myles M,Murdoch B,Keeney M.The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression..Proc Natl Acad Sci U S A2000;97:14626-31 PMCID:PMC18969

[75]

Day RB.Regulation of neutrophil trafficking from the bone marrow..Cell Mol Life Sci2012;69:1415-23

[76]

Sallusto F.Chemokines and leukocyte traffic..Nat Immunol2008;9:949-52

[77]

Sallusto F,Lanzavecchia A.The role of chemokine receptors in primary, effector, and memory immune responses..Annu Rev Immunol2000;18:593-620

[78]

Bussmann J.Chemokine-guided cell migration and motility in zebrafish development..EMBO J2015;34:1309-18 PMCID:PMC4491993

[79]

Vicenzi E,Poli G.The puzzling role of CXCR4 in human immunodeficiency virus infection..Theranostics2013;3:18-25 PMCID:PMC3563077

[80]

Gulino AV.WHIM syndrome: a genetic disorder of leukocyte trafficking..Curr Opin Allergy Clin Immunol2003;3:443-50

[81]

Balkwill F.The significance of cancer cell expression of the chemokine receptor CXCR4..Semin Cancer Biol2004;14:171-9

[82]

Chatterjee S,Nimmagadda S.The intricate role of CXCR4 in cancer..Adv Cancer Res2014;124:31-82 PMCID:PMC4322894

[83]

Saini V,Majetschak M.CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin..J Biol Chem2010;285:15566-76 PMCID:PMC2865327

[84]

Bernhagen J,Lue H,Zernecke A.MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment..Nat Med2007;13:587-96

[85]

Lourenco S,Kalber T,Floto RA.Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors..J Immunol2015;194:3463-74 PMCID:PMC4374168

[86]

Shin HN,Ku JL.Stromal cell-derived factor-1alpha and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells..Int J Mol Med2012;30:1537-43

[87]

Lu J,Schmid H,Gawaz M.CXCL14 as an emerging immune and inflammatory modulator..J Inflamm (Lond)2016;13:1 PMCID:PMC4700668

[88]

Muller A,Soto H,Catron D.Involvement of chemokine receptors in breast cancer metastasis..Nature2001;410:50-6

[89]

Weidle UH,Kollmorgen G.Molecular mechanisms of bone metastasis..Cancer Genomics Proteomics2016;13:1-12

[90]

Ottewell PD,Holen I.Molecular alterations that drive breast cancer metastasis to bone..Bonekey Rep2015;4:643 PMCID:PMC4371414

[91]

Martinez-Ordonez A,Cabezas P,Sendon-Lago J.Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis..Oncogene2018;37:1430-44

[92]

Seoane S,Eiro N,Garcia-Caballero L.POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages..J Pathol2019;249:381-94

[93]

Tulotta C,Beletkaia E,Tarbashevich K.Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model..Dis Model Mech2016;9:141-53 PMCID:PMC4770151

[94]

Cook AM,Nowak AK.Chemotherapy and immunotherapy: mapping the road ahead..Curr Opin Immunol2016;39:23-9

[95]

Galluzzi L,Bravo-San Pedro JM,Senovilla L.Classification of current anticancer immunotherapies..Oncotarget2014;5:12472-508 PMCID:PMC4350348

[96]

Tchernychev B,Sachdev P,Haggis L.Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells..Proc Natl Acad Sci U S A2010;107:22255-9 PMCID:PMC3009824

[97]

Walters KB,Surfus JC,Huttenlocher A.Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome..Blood2010;116:2803-11 PMCID:PMC2974588

[98]

Isles HM,Robertson AL,Prince LR.The CXCL12/CXCR4 signaling axis retains neutrophils at inflammatory sites in Zebrafish..Front Immunol2019;10:1784 PMCID:PMC6684839

[99]

Tulotta C,Chen Q,Meijer AH.CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells..Sci Rep2019;9:2399 PMCID:PMC6382824

[100]

Demicheli R,Hrushesky WJ,Gukas ID.The effects of surgery on tumor growth: a century of investigations..Ann Oncol2008;19:1821-8

[101]

Sounni NE.Targeting the tumor microenvironment for cancer therapy..Clin Chem2013;59:85-93

AI Summary AI Mindmap
PDF

10

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/